欢迎访问《标记免疫分析与临床》官方网站!
临床研究

缺血修饰白蛋白、肌钙蛋白、肌红蛋白、肌酸激酶同工酶检测在急性冠状动脉综合征早期发现中的应用

展开
  • 上海中医药大学附属曙光医院检验科,上海 201203

收稿日期: 2014-07-17

  修回日期: 2014-08-11

  网络出版日期: 2014-12-26

基金资助

国家高技术研究发展计划(863计划)课题资助,课题编号:2011AA02A111

Clinical Values of IMA, cTnI, MYO and CK-MB in Early Diagnosis of Acute Coronary Syndrome

Expand
  • Department of Clinical Laboratory, Shuguang Hospital affiliated to Shanghai Chinese Medical University, Shanghai 201203, China

Received date: 2014-07-17

  Revised date: 2014-08-11

  Online published: 2014-12-26

摘要

目的 探讨缺血修饰白蛋白(IMA)、肌钙蛋白(cTnI)、肌红蛋白(MYO)、肌酸激酶同工酶(CK-MB)检测在急性冠状动脉综合征的早期发现中的应用价值。方法 选择100例急性冠状动脉综合征(ACS)患者,在胸痛发作后3小时内检测缺血修饰白蛋白(IMA)、肌钙蛋白(cTnI)、肌红蛋白(MYO),肌酸激酶同工酶(CK-MB),同时选择100例健康查体者为对照组,做相同检测,观察各种心肌标志物的变化。结果 ACS组与对照组的检测结果进行对比,4项指标的差异均具有统计学意义(P<0.05)。ROC下曲线面积显示,IMA仅次于cTnI,高于MYO和CK-MB。结论 IMA、MYO、cTnI、CK-MB 联合检测在急性冠脉综合征( ACS) 早期诊断中具有重要的临床意义。

本文引用格式

王依屹,张 珏,王晓乐 . 缺血修饰白蛋白、肌钙蛋白、肌红蛋白、肌酸激酶同工酶检测在急性冠状动脉综合征早期发现中的应用[J]. 标记免疫分析与临床, 2014 , 21(6) : 671 . DOI: 10.11748/bjmy.issn.1006-1703.2014.06.015

Abstract

Objective To explore the clinical value of Ischemia modified albumin (IMA),Cardiac troponin I (cTnI),Myohemoglobin (MYO) and Creatine kinase isozymes (CK-MB) detection in the early diagnosis of acute coronary syndrome (ACS). Methods The serum levels of IMA, cTnI, MYO and CK-MB in 100 patients with acute coronary syndrome (ACS) at 3 hours after chest pain and in 100 healthy cases were detected. Results There were significantly difference on the IMA, cTnI, MYO and CK-MB between ACS group and control group (P<0.05). The areas under ROC curve in ACS group was lower than cTnI, but higher than MYO and CK-MB. Conclusion The combined detection of IMA, cTnI, MYO and CK-MB in acute coronary syndrome have a significant clinical value in the early diagnosis of ACS.
文章导航

/